t. 647-964-9600

 

Global reach of precision treatments and tools in cancer

Posted Dec 1st, 2017 in Posts

Global reach of precision treatments and tools in cancer

In the new precision oncology era, clinicians are using information from complex laboratory and imaging results to define the genetic and microscopic-molecular features that can assign a fingerprint of an individual patient’s cancer.  This type of personalized tumor characterization can then more effectively and safely help to inform and improved cancer diagnosis and management. 

These computational methods are also being applied to patient’s blood samples to analyse features of circulating free tumor cell DNA, if present… although such testing is still in preliminary stages, these methods have been able to detect early-stage cancers before they are symptomatic or visualized.

See this article from researchers in Southern California for more information on the clinical applications of circulating tumor DNA: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136923/



 

find out if blueguide can help.

During your first contact with blueguide, we'll determine if we can help you. There is no risk, and no obligation. Just people who care.

learn more